Literature DB >> 10717146

Radiosurgery for Intracranial Malignancies.

.   

Abstract

Radiosurgery was historically designed as a technology to be used for the treatment of functional disorders, benign tumors, and vascular malformations. In the last 5 years, malignant lesions have become an increasingly common target for the radiosurgeon. In fact, by 1994 the most common disease treated with radiosurgery in the United States was metastatic disease. Published data suggest that radiosurgery offers excellent local control for intracranial metastatic lesions regardless of location or histology with the majority of patients demonstrating an improved quality of life. Recent information from the Joint Center for Radiation Therapy suggests that radiosurgery compares favorably with interstitial brachytherapy for both recurrent as well as in newly diagnosed patients with malignant gliomas in terms of improved survival and the need of surgery and steroid support for symptomatic radiation changes. Prospective studies (Phase I through III) are ongoing to determine the ultimate role of radiosurgery in the management of patients with newly diagnosed and recurrent malignant gliomas, recurrent pediatric brain tumors disease, and patients with single or multiple intracranial metastases.

Entities:  

Year:  1995        PMID: 10717146     DOI: 10.1054/SRAO00500225

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  3 in total

1.  [The radio surgery of brain metastases].

Authors:  G Becker
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

2.  Permanent low-activity iodine-125 implants for cerebral metastases.

Authors:  M Schulder; P M Black; D C Shrieve; E Alexander; J S Loeffler
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

3.  Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone.

Authors:  Anna Likhacheva; Chelsea C Pinnix; Neil Parikh; Pamela K Allen; Nandita Guha-Thakurta; Mary McAleer; Erik P Sulman; Anita Mahajan; Almon Shiu; Dershan Luo; Max Chiu; Paul D Brown; Sujit S Prabhu; Eric L Chang
Journal:  J Neurosurg       Date:  2012-12       Impact factor: 5.115

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.